Just diagnosed with Riboflavin transporter deficiency?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Riboflavin transporter deficiency, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Riboflavin transporter deficiency hub →Overview
Riboflavin transporter deficiency is a rare condition. Also known as Brown-Vialetto-van Laere syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Riboflavin transporter deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:97229 · OMIM 211500, 211530, 614707 · ICD-10 G12.2 · GARD 0009993
Find care for Riboflavin transporter deficiency
Authoritative references for Riboflavin transporter deficiency
Research & market landscape for Riboflavin transporter deficiency
Following Riboflavin transporter deficiency for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Riboflavin transporter deficiency — the real-world landscape behind the condition, in one place.
- Latest Riboflavin transporter deficiency research on PubMed ↗
- Recruiting Riboflavin transporter deficiency trials on ClinicalTrials.gov ↗
- Explore the Riboflavin transporter deficiency research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Riboflavin transporter deficiency and every rare condition. See how Tomeko works with industry →
Common questions
What is Riboflavin transporter deficiency?
Riboflavin transporter deficiency is a rare condition. Also known as Brown-Vialetto-van Laere syndrome. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Riboflavin transporter deficiency together in one place.
What are the symptoms of Riboflavin transporter deficiency?
Symptoms of Riboflavin transporter deficiency vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Riboflavin transporter deficiency.
How is Riboflavin transporter deficiency treated?
Treatment for Riboflavin transporter deficiency depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Riboflavin transporter deficiency, and review current options with them.
What causes Riboflavin transporter deficiency — is it genetic?
The cause and inheritance of Riboflavin transporter deficiency are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Riboflavin transporter deficiency can explain what it means for you and your family.
I was just diagnosed with Riboflavin transporter deficiency — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Riboflavin transporter deficiency, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Riboflavin transporter deficiency?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Riboflavin transporter deficiency, filtered to your area.
Are there clinical trials for Riboflavin transporter deficiency?
Tomeko shows live, recruiting studies for Riboflavin transporter deficiency from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion